Liu CJ - Search Results

1

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection.

Liu CH, Fang YJ, Liu CJ, Su TH, Huang SC, Tseng TC, Wu JH, Chen PJ, Kao JH. Liu CH, et al. Among authors: liu cj. J Clin Med. 2023 Mar 3;12(5):2020. doi: 10.3390/jcm12052020. J Clin Med. 2023. PMID: 36902807 Free PMC article.

2

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Su TH, et al. Among authors: liu ch, liu cj. Aliment Pharmacol Ther. 2019 Feb;49(3):331-339. doi: 10.1111/apt.15101. Epub 2018 Dec 27. Aliment Pharmacol Ther. 2019. PMID: 30592071

3

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Su TH, et al. Among authors: liu ch, liu cj. Aliment Pharmacol Ther. 2019 Mar;49(5):589-598. doi: 10.1111/apt.15132. Epub 2019 Jan 25. Aliment Pharmacol Ther. 2019. PMID: 30681172

4

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.

Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: liu cj. J Gastroenterol Hepatol. 2019 Nov;34(11):1977-1983. doi: 10.1111/jgh.14672. Epub 2019 May 27. J Gastroenterol Hepatol. 2019. PMID: 30931537

5

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease.

Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ. Huang SC, et al. Among authors: liu cj. Gut Liver. 2021 May 15;15(3):451-458. doi: 10.5009/gnl20218. Gut Liver. 2021. PMID: 33431715 Free PMC article.

6

Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.

Tseng TC, Liu CJ, Yang WT, Hsu CY, Hong CM, Su TH, Tsai CH, Chen CL, Yang HC, Liu CH, Chen HH, Chen PJ, Kao JH. Tseng TC, et al. Among authors: liu ch, liu cj. Aliment Pharmacol Ther. 2021 Apr;53(8):908-918. doi: 10.1111/apt.16266. Epub 2021 Jan 19. Aliment Pharmacol Ther. 2021. PMID: 33465271

7

Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.

Hsieh MH, Bair MJ, Tsai PC, Tseng KC, Lo CC, Chen CY, Kuo HT, Hung CH, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Huang JF, Dai CY, Yu ML, Chuang WL; T-COACH investigators. Hsieh MH, et al. Among authors: liu ch, liu cj. J Gastroenterol Hepatol. 2021 Aug;36(8):2247-2254. doi: 10.1111/jgh.15469. Epub 2021 Mar 30. J Gastroenterol Hepatol. 2021. PMID: 33624849

8

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).

Hsu WF, Tsai PC, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Su WW, Chu CH, Chen CJ, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Huang JF, Dai CY, Chuang WL, Yu ML, Peng CY. Hsu WF, et al. Among authors: liu ch, liu cj. J Gastroenterol Hepatol. 2021 Oct;36(10):2884-2892. doi: 10.1111/jgh.15538. Epub 2021 May 21. J Gastroenterol Hepatol. 2021. PMID: 33963615

9

Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.

Liu CH, Peng CY, Kao WY, Yang SS, Shih YL, Lin CL, Tsai MK, Lee CY, Chang CC, Wu JH, Liu CJ, Su TH, Tseng TC, Chen PJ, Kao JH. Liu CH, et al. Among authors: liu cj. Aliment Pharmacol Ther. 2022 Feb;55(4):434-445. doi: 10.1111/apt.16697. Epub 2021 Nov 13. Aliment Pharmacol Ther. 2022. PMID: 34773272

10

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.

Lin CL, Tai CM, Huang JF, Liu CJ, Chen HF, Cheng PN, Chen CY, Peng CY, Wang CC, Weng SH, Tseng TC, Kao JH. Lin CL, et al. Among authors: liu cj. J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13. J Gastroenterol Hepatol. 2022. PMID: 35790343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,256 results

Search Page

Filters